FDA Clearance Tracker · P030023-S009
Capsular Tension Ring (CTR) and RingJect
Last checked: Nov 20, 2026Latest source record: Aug 1, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Aug 1, 2024
Approved
Time to decision
855 days
Received Mar 30, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P030023-S009
- Device name
- Capsular Tension Ring (CTR) and RingJect
- Applicant
- Ophtec BV
- Applicant location
- Groningen
- Received
- Mar 30, 2022
- Decided
- Aug 1, 2024
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P030023
Device type
- Device type
- Ring, endocapsular (MRJ)
- Device class
- Class III
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
approval for a manufacturing site located at Sterigenics Germany GmbH, FEI 3006003617, Kasteler Str. 45 Wiesbaden Hesse, 65203, Germany, for Ethylene Oxide Sterilization of Capsular Tension Ring (CTS) and RingJect.
Source documents
Other decisions for Ophtec BV
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.